| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.385 | 3.152 | 3.159 | 1.602 | 1.468 | 0 | 0 | 768 | 1.759 | 10.000 |
| Total Income - EUR | 3.385 | 3.152 | 3.414 | 1.602 | 1.468 | 0 | 0 | 768 | 1.759 | 10.000 |
| Total Expenses - EUR | 3.725 | 3.687 | 2.021 | 2.268 | 2.234 | 1.738 | 764 | 732 | 627 | 5.122 |
| Gross Profit/Loss - EUR | -340 | -534 | 1.393 | -667 | -767 | -1.738 | -764 | 37 | 1.132 | 4.878 |
| Net Profit/Loss - EUR | -442 | -629 | 1.291 | -715 | -811 | -1.738 | -764 | 31 | 951 | 3.303 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Avicena Ibnsina Comimpex S.r.l.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 597 | 0 | 354 | 0 | 5 | 4 | 102 | 477 | 404 | 77 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 95 | 0 | 0 | 0 |
| Receivables | 463 | 0 | 0 | 0 | 3 | 4 | 7 | 0 | 0 | 9 |
| Cash | 134 | 0 | 354 | 0 | 2 | 0 | 0 | 477 | 404 | 68 |
| Shareholders Funds | -14.183 | -14.572 | -13.014 | -13.477 | -14.032 | -15.459 | -16.271 | -16.191 | -15.150 | -72.057 |
| Social Capital | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 | 500 |
| Debts | 14.780 | 14.572 | 13.368 | 13.533 | 14.091 | 15.463 | 16.373 | 16.668 | 15.554 | 72.134 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 1 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Avicena Ibnsina Comimpex S.r.l.